2005
DOI: 10.1213/01.ane.0000153499.10558.f3
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Sildenafil on Pulmonary Embolism-Induced Oxidative Stress and Pulmonary Hypertension

Abstract: Acute pulmonary embolism (APE) is a major cause of pulmonary hypertension and death. We examined the effects of sildenafil on the hemodynamic changes caused by APE in anesthetized dogs. Sham-operated dogs (n = 3) received only saline. APE was induced by stepwise IV injections of 300 mum microspheres in amounts adjusted to increase mean pulmonary artery pressures by 20 mm Hg. Hemodynamic evaluation was performed at baseline, after APE was induced, and then after sildenafil 0.25 mg/kg (n = 8), or sildenafil 1 mg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
44
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 74 publications
(50 citation statements)
references
References 30 publications
6
44
0
Order By: Relevance
“…Recent results from studies using the dual endothelin receptor antagonist bosentan (27), as well as studies of a more selective ET A receptor antagonist (28), show alleviation of symptoms and slowing in the progression of disease in some patients. The reduced expression of NO synthase, the enzyme that generates NO (29), suggests that treatment with phosphodiesterase V inhibitors such as sildenafil to prolong the NO-mediated increase in cGMP would be effective in dilating PAs (30) as well as in therapies for IPAH and APAH associated with collagen vascular disease (31), congenital cardiac left-to-right shunts (30), persistent PH of the newborn (32), PAH associated with hemoglobinopathies such as sickle cell disease (33), and PH related to thrombotic and embolic disorders (34). While one study reported that sildenafil can improve PAH in patients refractory to i.v.…”
Section: An Imbalance Between Vasodilators and Vasoconstrictors And Pahmentioning
confidence: 99%
“…Recent results from studies using the dual endothelin receptor antagonist bosentan (27), as well as studies of a more selective ET A receptor antagonist (28), show alleviation of symptoms and slowing in the progression of disease in some patients. The reduced expression of NO synthase, the enzyme that generates NO (29), suggests that treatment with phosphodiesterase V inhibitors such as sildenafil to prolong the NO-mediated increase in cGMP would be effective in dilating PAs (30) as well as in therapies for IPAH and APAH associated with collagen vascular disease (31), congenital cardiac left-to-right shunts (30), persistent PH of the newborn (32), PAH associated with hemoglobinopathies such as sickle cell disease (33), and PH related to thrombotic and embolic disorders (34). While one study reported that sildenafil can improve PAH in patients refractory to i.v.…”
Section: An Imbalance Between Vasodilators and Vasoconstrictors And Pahmentioning
confidence: 99%
“…In conditions associated with increased free radical release and oxidative stress, intracellular cGMP accumulation has been shown to reduce tissue injury. 35 …”
Section: Mechanisms Of Cardioprotective Effects Of Cinaciguat Againstmentioning
confidence: 99%
“…Reactive arterial vasoconstriction leads to pulmonary hypertension. Acute pulmonary hypertension may cause right ventricular failure (acute cor pulmonale) and finally cardiogenic shock (14,16). In addition to all these events, the existence of oxidative stress in the pathophysiology of PE was shown by previous studies (6,(17)(18)(19).…”
Section: Discussionmentioning
confidence: 88%